- Home
- MNY vs BRNS Comparison
MNY vs BRNS Comparison
Compare MNY & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- BRNS
- Stock Information
- Founded
- MNY 2014
- BRNS 2016
- Country
- MNY Singapore
- BRNS United Kingdom
- Employees
- MNY N/A
- BRNS N/A
- Industry
- MNY
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- BRNS Health Care
- Exchange
- MNY Nasdaq
- BRNS Nasdaq
- Market Cap
- MNY 43.9M
- BRNS 42.8M
- IPO Year
- MNY N/A
- BRNS 2021
- Fundamental
- Price
- MNY $1.86
- BRNS $1.38
- Analyst Decision
- MNY Strong Buy
- BRNS Strong Buy
- Analyst Count
- MNY 1
- BRNS 1
- Target Price
- MNY $4.00
- BRNS $3.00
- AVG Volume (30 Days)
- MNY 652.9K
- BRNS 3.8M
- Earning Date
- MNY 09-18-2025
- BRNS 08-11-2025
- Dividend Yield
- MNY N/A
- BRNS N/A
- EPS Growth
- MNY N/A
- BRNS N/A
- EPS
- MNY N/A
- BRNS N/A
- Revenue
- MNY $71,649,746.00
- BRNS $14,969,000.00
- Revenue This Year
- MNY $16.97
- BRNS N/A
- Revenue Next Year
- MNY $19.35
- BRNS N/A
- P/E Ratio
- MNY N/A
- BRNS N/A
- Revenue Growth
- MNY N/A
- BRNS 4381.74
- 52 Week Low
- MNY $0.55
- BRNS $0.64
- 52 Week High
- MNY $2.15
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- MNY 64.58
- BRNS 51.09
- Support Level
- MNY $1.60
- BRNS $1.28
- Resistance Level
- MNY $2.13
- BRNS $2.01
- Average True Range (ATR)
- MNY 0.27
- BRNS 0.29
- MACD
- MNY -0.02
- BRNS -0.05
- Stochastic Oscillator
- MNY 68.82
- BRNS 6.13
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.